Skip to main content

Table 2 Onset, source, and non-SARS-CoV-2 pathogensa by SARS-CoV-2 and testing status

From: A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19

Specimen onset, source, and pathogens

n (% positive specimens)

Untested for SARS-CoV-2

Tested for SARS-CoV-2

P value

SARS-CoV-2 negative

SARS-CoV-2 positive

Any positive non-SARS-CoV-2 specimenb

73,315 (100%)

38,753 (100%)

5012 (100%)

 

Timing of non-SARS-CoV-2 pathogen detection

   

< 0.05

 Admission period

59,016 (80.5%)

30,141 (77.8%)

2889 (57.6%)

 

 Hospital-onset period (> 3 days)

14,299 (19.5%)

8612 (22.2%)

2123 (42.4%)

 

Non-SARS-CoV-2 specimen source

   

< 0.05

 Urine

20,807 (28.4%)

10,077 (26.0%)

1697 (33.9%)

 

 Respiratory

9626 (13.1%)

5435 (14.0%)

1228 (24.5%)

 

 Blood

11,185 (15.3%)

9530 (24.6%)

1020 (20.4%)

 

 Other

16,393 (22.4%)

7474 (19.3%)

776 (15.5%)

 

 Skin/Wound

14,033 (19.1%)

5698 (14.7%)

271 (5.3%)

 

 Intra-abdominal

1271 (1.7%)

539 (1.4%)

20 (0.4%)

 

Non-SARS-CoV-2 pathogensa

 Any bacteria

56,215 (76.7%)

30,952 (79.9%)

3972 (79.2%)

 

  Gram-negative

31, 887 (43.5%)

17,087 (44.1%)

2280 (45.5%)

< 0.05

   Enterobacterales

22,289 (30.4%)

11,939 (30.8%)

1594 (31.8%)

0.06

   Pseudomonas aeruginosa

2729 (3.8%)

1837 (4.7%)

324 (6.5%)

< 0.05

   Stenotrophomonas maltophilia

302 (0.4%)

238 (0.6%)

39 (0.8%)

< 0.05

   Acinetobacter baumannii

145 (0.2%)

84 (0.2%)

13 (0.3%)

0.56

  Gram-positive

24,035 (32.8%)

13,532 (34.9%)

1670 (33.3%)

<  0.05

   Staphylococcus aureus

10,147 (13.8%)

6120 (15.8%)

689 (13.7%)

< 0.05

   Enterococcus spp.

4124 (5.6%)

2357 (6.1%)

357 (7.1%)

< 0.05

   Streptococcus pneumoniae

682 (0.9%)

513 (1.3%)

94 (1.9%)

< 0.05

 Non-SARS-CoV-2 virus

13,150 (17.9)

5403 (13.9%)

543 (10.8%)

< 0.05

  Respiratory viruses

4398 (6.0%)

1170 (3.0%)

111 (2.2%)

< 0.05

 Fungi

2124 (2.9%)

1328 (3.4%)

280 (5.6%)

< 0.05

  Candida spp.

2990 (4.1%)

1764 (4.6%)

410 (8.2%)

< 0.05

  Aspergillus spp.

104 (0.1%)

108 (0.3%)

6 (0.1%)

< 0.05

  1. aAny bacteria, fungus, or virus other than SARS-CoV-2
  2. bPatients could have more than one positive specimen and pathogen